articleTherapeutic Advances in Medical OncologyNov 1, 2011BRONZE OA

An overview of the c-MET signaling pathway

Ontario Institute for Cancer Research · Princess Margaret Cancer Centre

PubMed
Indexed incrossrefdoajpubmed

Abstract

C-MET is a receptor tyrosine kinase that, after binding with its ligand, hepatocyte growth factor, activates a wide range of different cellular signaling pathways, including those involved in proliferation, motility, migration and invasion. Although c-MET is important in the control of tissue homeostasis under normal physiological conditions, it has also been found to be aberrantly activated in human cancers via mutation, amplification or protein overexpression. This paper provides an overview of the c-MET signaling pathway, including its role in the development of cancers, and provides a rationale for targeting the pathway as a possible treatment option.

Citation impact

860
total citations
FWCI
5.93
Percentile
100%
References
120
Citations per year

Authors

2

Topics & keywords

Keywords
  • Signal transduction
  • Hepatocyte growth factor
  • Receptor tyrosine kinase
  • Cancer research
  • Medicine
  • Tyrosine kinase
  • Cell biology
  • C-Met
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.